US Stock MarketDetailed Quotes

DNTH Dianthus Therapeutics

Watchlist
  • 19.990
  • +0.120+0.60%
Close Mar 28 16:00 ET
  • 19.990
  • 0.0000.00%
Post 16:01 ET
642.18MMarket Cap-7.84P/E (TTM)

Dianthus Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
120.63%6.24M
190.15%1.33M
135.06%2.17M
92.26%1.86M
83.61%874K
-55.96%2.83M
-61.11%457K
-21.23%924K
969K
476K
Operating revenue
120.63%6.24M
190.15%1.33M
135.06%2.17M
92.26%1.86M
83.61%874K
-55.96%2.83M
-61.11%457K
-21.23%924K
--969K
--476K
Cost of revenue
Gross profit
Operating expense
111.96%108.1M
147.83%33.24M
92.24%32.07M
88.83%24.07M
129.42%18.72M
41.19%51M
13.02%13.41M
76.97%16.68M
12.75M
8.16M
Selling and administrative expenses
37.64%24.99M
47.43%6.83M
-25.16%6.53M
140.65%6M
143.94%5.64M
169.30%18.16M
127.39%4.63M
294.88%8.72M
--2.49M
--2.31M
-General and administrative expense
37.64%24.99M
47.43%6.83M
-25.16%6.53M
140.65%6M
143.94%5.64M
169.30%18.16M
127.39%4.63M
294.88%8.72M
--2.49M
--2.31M
Research and development costs
153.05%83.11M
200.80%26.41M
220.90%25.54M
76.24%18.07M
123.67%13.08M
11.78%32.84M
-10.68%8.78M
10.28%7.96M
--10.25M
--5.85M
Operating profit
-111.45%-101.86M
-146.34%-31.92M
-89.73%-29.9M
-88.55%-22.2M
-132.25%-17.84M
-62.17%-48.17M
-21.16%-12.96M
-90.93%-15.76M
-11.78M
-7.68M
Net non-operating interest income expense
264.50%17.37M
63.26%3.99M
332.81%4.45M
585.30%4.71M
596.70%4.22M
316.07%4.76M
281.88%2.44M
146.88%1.03M
687K
606K
Non-operating interest income
264.50%17.37M
63.26%3.99M
332.81%4.45M
585.30%4.71M
596.70%4.22M
316.07%4.76M
281.88%2.44M
146.88%1.03M
--687K
--606K
Other net income (expense)
-224.14%-470K
-907.84%-514K
1,006.45%281K
-117.65%-111K
-950.00%-126K
-272.62%-145K
19.05%-51K
-157.41%-31K
-51K
-12K
Gain on sale of security
198.82%84K
-312.50%-132K
1,718.75%259K
-10.71%-31K
-33.33%-12K
-162.50%-85K
-60.00%-32K
-128.57%-16K
---28K
---9K
Other non- operating income (expenses)
-823.33%-554K
-1,910.53%-382K
246.67%22K
-247.83%-80K
-3,700.00%-114K
-15.38%-60K
55.81%-19K
-650.00%-15K
---23K
---3K
Income before tax
-95.08%-84.97M
-169.24%-28.44M
-70.52%-25.17M
-58.05%-17.61M
-93.93%-13.75M
-52.95%-43.56M
-4.42%-10.56M
-89.66%-14.76M
-11.14M
-7.09M
Income tax
Net income
-95.08%-84.97M
-169.24%-28.44M
-70.52%-25.17M
-58.05%-17.61M
-93.93%-13.75M
-52.95%-43.56M
-4.42%-10.56M
-89.66%-14.76M
-11.14M
-7.09M
Net income continuous Operations
-95.08%-84.97M
-169.24%-28.44M
-70.52%-25.17M
-58.05%-17.61M
-93.93%-13.75M
-52.95%-43.56M
-4.42%-10.56M
-89.66%-14.76M
---11.14M
---7.09M
Minority interest income
Net income attributable to the parent company
-95.08%-84.97M
-169.24%-28.44M
-70.52%-25.17M
-58.05%-17.61M
-93.93%-13.75M
-52.95%-43.56M
-4.42%-10.56M
-89.66%-14.76M
-11.14M
-7.09M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-95.08%-84.97M
-169.24%-28.44M
-70.52%-25.17M
-58.05%-17.61M
-93.93%-13.75M
-52.95%-43.56M
-4.42%-10.56M
-89.66%-14.76M
-11.14M
-7.09M
Basic earnings per share
69.82%-2.55
-13.63%-0.81
80.42%-0.74
32.16%-0.51
-12.87%-0.54
-339.70%-8.45
-4.42%-0.7129
-619.56%-3.78
-0.7518
-0.4784
Diluted earnings per share
69.82%-2.55
-13.63%-0.81
80.42%-0.74
32.16%-0.51
-12.87%-0.54
-339.70%-8.45
-4.42%-0.7129
-619.56%-3.78
-0.7518
-0.4784
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 120.63%6.24M190.15%1.33M135.06%2.17M92.26%1.86M83.61%874K-55.96%2.83M-61.11%457K-21.23%924K969K476K
Operating revenue 120.63%6.24M190.15%1.33M135.06%2.17M92.26%1.86M83.61%874K-55.96%2.83M-61.11%457K-21.23%924K--969K--476K
Cost of revenue
Gross profit
Operating expense 111.96%108.1M147.83%33.24M92.24%32.07M88.83%24.07M129.42%18.72M41.19%51M13.02%13.41M76.97%16.68M12.75M8.16M
Selling and administrative expenses 37.64%24.99M47.43%6.83M-25.16%6.53M140.65%6M143.94%5.64M169.30%18.16M127.39%4.63M294.88%8.72M--2.49M--2.31M
-General and administrative expense 37.64%24.99M47.43%6.83M-25.16%6.53M140.65%6M143.94%5.64M169.30%18.16M127.39%4.63M294.88%8.72M--2.49M--2.31M
Research and development costs 153.05%83.11M200.80%26.41M220.90%25.54M76.24%18.07M123.67%13.08M11.78%32.84M-10.68%8.78M10.28%7.96M--10.25M--5.85M
Operating profit -111.45%-101.86M-146.34%-31.92M-89.73%-29.9M-88.55%-22.2M-132.25%-17.84M-62.17%-48.17M-21.16%-12.96M-90.93%-15.76M-11.78M-7.68M
Net non-operating interest income expense 264.50%17.37M63.26%3.99M332.81%4.45M585.30%4.71M596.70%4.22M316.07%4.76M281.88%2.44M146.88%1.03M687K606K
Non-operating interest income 264.50%17.37M63.26%3.99M332.81%4.45M585.30%4.71M596.70%4.22M316.07%4.76M281.88%2.44M146.88%1.03M--687K--606K
Other net income (expense) -224.14%-470K-907.84%-514K1,006.45%281K-117.65%-111K-950.00%-126K-272.62%-145K19.05%-51K-157.41%-31K-51K-12K
Gain on sale of security 198.82%84K-312.50%-132K1,718.75%259K-10.71%-31K-33.33%-12K-162.50%-85K-60.00%-32K-128.57%-16K---28K---9K
Other non- operating income (expenses) -823.33%-554K-1,910.53%-382K246.67%22K-247.83%-80K-3,700.00%-114K-15.38%-60K55.81%-19K-650.00%-15K---23K---3K
Income before tax -95.08%-84.97M-169.24%-28.44M-70.52%-25.17M-58.05%-17.61M-93.93%-13.75M-52.95%-43.56M-4.42%-10.56M-89.66%-14.76M-11.14M-7.09M
Income tax
Net income -95.08%-84.97M-169.24%-28.44M-70.52%-25.17M-58.05%-17.61M-93.93%-13.75M-52.95%-43.56M-4.42%-10.56M-89.66%-14.76M-11.14M-7.09M
Net income continuous Operations -95.08%-84.97M-169.24%-28.44M-70.52%-25.17M-58.05%-17.61M-93.93%-13.75M-52.95%-43.56M-4.42%-10.56M-89.66%-14.76M---11.14M---7.09M
Minority interest income
Net income attributable to the parent company -95.08%-84.97M-169.24%-28.44M-70.52%-25.17M-58.05%-17.61M-93.93%-13.75M-52.95%-43.56M-4.42%-10.56M-89.66%-14.76M-11.14M-7.09M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -95.08%-84.97M-169.24%-28.44M-70.52%-25.17M-58.05%-17.61M-93.93%-13.75M-52.95%-43.56M-4.42%-10.56M-89.66%-14.76M-11.14M-7.09M
Basic earnings per share 69.82%-2.55-13.63%-0.8180.42%-0.7432.16%-0.51-12.87%-0.54-339.70%-8.45-4.42%-0.7129-619.56%-3.78-0.7518-0.4784
Diluted earnings per share 69.82%-2.55-13.63%-0.8180.42%-0.7432.16%-0.51-12.87%-0.54-339.70%-8.45-4.42%-0.7129-619.56%-3.78-0.7518-0.4784
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
8.950
eBay
EBAY
67.160
Collegium Pharmaceutical
COLL
29.710
4
Dorian LPG
LPG
22.500
5
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
12.325
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025